Meeting
2019 Gastrointestinal Cancers Symposium
Multiplatform profiling of pancreatic neuroendocrine tumors (PanNETs) identifies novel co-occurring pathogenic alterations and associations with clinicopathologic factors.
Authors
Michelle Guan
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA
Michelle Guan , Jun Gong , Andrew Eugene Hendifar , Richard Tuli , Veronica Placencio-Hickok , Joseph Bender , Edik Matthew Blais , Emanuel Petricoin III
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 211)
DOI
10.1200/JCO.2019.37.4_suppl.211
Abstract #
211
Poster Bd #
B7
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Utility of comprehensive genomic profiling (CGP) to distinguish neoplasms pathologically diagnosed as PanNETs and PanNECs and identify potentially actionable genomic alterations (GA).
First Author: Aatur D. Singhi
Poster
2022 ASCO Annual Meeting
Genomic correlates of response to capecitabine and temozolomide (CAPTEM) in pancreatic neuroendocrine tumors.
First Author: Patrick Lee
Poster
2022 ASCO Annual Meeting
Molecular alterations associated with rapid progression following CDK4/6 inhibitors (CDKi) in metastatic hormone receptor–positive breast cancer (mHRBC).
First Author: Malinda T West
Poster
2020 Genitourinary Cancers Symposium
mTOR pathway alterations in chromophobe renal cell carcinoma: Impact on metastasis development and overall survival.
First Author: Pablo Maroto